Marvell's AI infrastructure business just posted record data center revenue and management keeps raising its multiyear outlook, yet the stock still sits well below its 52-week high. Here is what the numbers say about…
SpaceX stock just slipped below its IPO price on a fraction of the supply that sent shares surging weeks ago, and the calendar shows two far larger unlock events still ahead before year-end.
JEPI has delivered exactly what it promised in 2026, and investors are furious. Before writing off the fund, consider what conditions would need to reverse for laggards to become leaders, and whether those conditions…
A historic one-session rally in a cancer vaccine stock is already unwinding, and Wall Street analysts disagree sharply on whether the reversal reflects a trade gone cold or an opportunity that the market is…
Scott Bessent just made a move in the bond market that sent silver surging past gold in a single session, and the reason it worked reveals something important about where precious metals are actually…
Salesforce shares are down more than 20% this year, yet the valuation, the AI numbers, and the prediction markets are all pointing toward the same date on the calendar.
A Medicare surcharge created to target the wealthiest 5% of retirees now routinely ambushes schoolteachers and postal workers, and the trap gets worse the more carefully you planned your retirement.
A Chicago firm you have probably never heard of holds a staggering multiple of XRP ETF shares compared to Morgan Stanley, but the real story is buried in what that number actually reveals about…
Palantir just delivered the kind of quarter that silences critics, but with a valuation that makes even bulls nervous, the real debate is whether the growth story can actually justify what the market is…
BND has barely moved while stocks surge, and the temptation to cut losses and rotate into equities is growing louder. But the math behind that decision may be working against everyone who acts on…
The AI market cap race among the biggest tech giants reveals a brutal reshuffling of power, and one social media behemoth is watching its AI ambitions get priced into irrelevance while a private upstart…
Seaport Therapeutics just went public with a prodrug platform that has attracted board members from two of the biggest neuroscience acquisitions in recent history. The question is whether the same giants who funded those…
Trump's promise of economic warfare against Iran sent crude prices surging, but energy stocks have already soared 44% this year and a single ceasefire tweet could erase those gains in days. Here is how…
Advance Auto Parts stock cratered Thursday even as the company beat earnings estimates, leaving investors to question whether the headline numbers tell the real story about consumer demand and the health of the entire…
Greg Abel's first full quarter running Berkshire's portfolio wiped out sixteen positions in one sweep, and OMAH shareholders are only now finding out what that means for the fund they thought they owned.